DalsnaFinance › Analyst accuracy › BTIG › DXCM target
BTIG raises DexCom stock price target to $90 on strong Q2 results
BTIG raised its price target on DexCom stock to $90 from $80 while maintaining a Buy rating following the company's second-quarter earnings report.
A fact about what BTIG published, as reported by Investing.com, not a recommendation from Dalsna Finance; BTIG is not affiliated with this site.
Full methodology: how targets are collected, scored, ranked and corrected, what each field means, and how to cite the data.